Clinical Trial Update: MR Guided Phase II Radiotherapy Dose Escalation in Unresectable Non-Metastatic Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase II study evaluating MR-guided radiotherapy dose escalation for unresectable non-metastatic pancreatic cancer; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: Medical College of Wisconsin | Conditions: Unresectable Pancreatic Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-02-10